Today, on European Day of Languages, we celebrate the richness of Europe’s linguistic and cultural diversity. At the EUDA, multilingualism is at the core of our work, helping us deliver evidence-based information on drugs to audiences across Europe – in their own languages.
Linguistic diversity — a pillar of inclusive communication
Multilingualism and accessibility lie at the heart of the EUDA’s Communication Strategy 2025-2028. Communicating in languages other than English increases impact, while promoting plain language supports clarity and machine translation, thereby…
Čtěte více
When our contribution to the COPOLAD III programme wrapped up in March this year, it marked the end of nearly three years of the latest collaboration between the European Union and Latin America and Caribbean (LAC) countries in the drugs field (1). But the story doesn’t end there. Today, we are revisiting that journey and unveiling new resources, including a summary of the project results and a video capturing its added value. Here are some of the highlights under the four project components (2).
Strengthening National Drug Observatories and Early Warning Systems
One of the…
Čtěte více
This week we are showcasing our new International Cooperation Framework (ICF), adopted by the EUDA Management Board in June. The ICF defines the agency’s vision and priorities for enhancing global collaboration on drug-related challenges. It follows the EUDA being given a stronger international role when it replaced the EMCDDA in July 2024 (1). This new role strengthens the agency’s capacity to monitor and analyse the external dimension of the drugs problem and increase EU preparedness on drugs.
Responding to a global challenge
Drugs are a transnational phenomenon, affecting communities…
Čtěte více
